In leukemia, CCL3 can induce multiple processes that support the dominant proliferation of tumor cells: (i) conversion of normal niche cells to leukemia-adapted cells; (ii) selective inhibition of normal HSPCs; (iii) mobilization of normal HSPCs from BM (43). This evidence concerns the gene CCL3 and neoplasm.